2004 Annual Meeting | Neuromuscular Therapy
| 07:00 PM - 07:35 PM |
Clinical Approach to the Management of the Muscular Dystrophies
John T. Kissel, MD, FÂé¶¹´«Ã½Ó³» |
|
| 07:35 PM - 08:10 PM |
Clinical Approach to the Management of ALS
Carlayne E. Jackson, MD, FÂé¶¹´«Ã½Ó³» |
|
| 08:10 PM - 08:45 PM |
What We Can Do When There is Nothing More We Can Do: The Role of Palliative Care
Robert M. Taylor, MD, FÂé¶¹´«Ã½Ó³» |
|
| 08:45 PM - 09:00 PM |
Questions and Answers
|
| John T. Kissel, MD, FÂé¶¹´«Ã½Ó³» | Dr. Kissel has nothing to disclose. |
| Carlayne E. Jackson, MD, FÂé¶¹´«Ã½Ó³» | Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Âé¶¹´«Ã½Ó³». The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital. |
| No disclosure on file | |
| Robert M. Taylor, MD, FÂé¶¹´«Ã½Ó³» | No disclosure on file |